Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
During these last years, new agents have dramatically improved the survival of the metastatic patients. Oligometastases represent a continuous field of interest in which the integration of metastases-directed therapy and drugs could further improve the oncologic outcomes. Herein a narrative review is performed regarding the main rationale in combin...
Alternative Titles
Full title
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c0301203d9194c2bbd78bd76d429581b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c0301203d9194c2bbd78bd76d429581b
Other Identifiers
ISSN
1748-717X
E-ISSN
1748-717X
DOI
10.1186/s13014-020-01544-0
